Cargando…

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer

BACKGROUND: Distant metastatic disease is frequently observed in inflammatory breast cancer (IBC), with a poor prognosis as a consequence. The aim of this study was to analyze the association of hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) based breast cancer subtypes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Uden, D. J. P., van Maaren, M. C., Strobbe, L. J. A., Bult, P., van der Hoeven, J. J., Siesling, S., de Wilt, J. H. W., Blanken-Peeters, C. F. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798447/ https://www.ncbi.nlm.nih.gov/pubmed/31623649 http://dx.doi.org/10.1186/s13058-019-1201-5

Ejemplares similares

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Follow‐up after breast cancer: Variations, best practices, and opportunities for improvement according to health care professionals
por: Ankersmid, Jet W., et al.
Publicado: (2021)

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
por: van der Meer, Daniël J., et al.
Publicado: (2020)

Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors
por: Ankersmid, J. W., et al.
Publicado: (2022)

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
por: Peeters, D J E, et al.
Publicado: (2014)

Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple‐negative breast cancer
por: Heeg, Erik, et al.
Publicado: (2019)

Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer
por: Moossdorff, M., et al.
Publicado: (2021)

Breast-conserving therapy versus mastectomy
por: van Maaren, Marissa C., et al.
Publicado: (2016)

The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study
por: van Nijnatten, T. J. A., et al.
Publicado: (2020)

External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients
por: Hueting, Tom A., et al.
Publicado: (2023)

Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival
por: Moncada-Torres, Arturo, et al.
Publicado: (2021)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design
por: Klaassen-Dekker, A., et al.
Publicado: (2023)

Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands
por: van Maaren, Marissa C., et al.
Publicado: (2022)

Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients
por: Mao, Jian-Hua, et al.
Publicado: (2017)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021)

The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer
por: Nagtegaal, I. D., et al.
Publicado: (2023)

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands
por: van Steenbeek, Cornelia D., et al.
Publicado: (2019)

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
por: Almeida, Cristina Ferreira, et al.
Publicado: (2021)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival
por: van Maaren, Marissa C, et al.
Publicado: (2017)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
por: Liefaard, M. C., et al.
Publicado: (2023)

A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients
por: van Maaren, Marissa C., et al.
Publicado: (2019)

Blood Flow and Glucose Metabolism in Stage IV Breast Cancer: Heterogeneity of Response During Chemotherapy
por: Krak, Nanda, et al.
Publicado: (2008)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Health care professionals' perspectives on shared decision making supported by personalised‐risk‐for‐recurrences‐calculations regarding surveillance after breast cancer
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Meta-Analysis
por: van Weers, S, et al.
Publicado: (2022)

Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands
por: van Bommel, Annnelotte, et al.
Publicado: (2019)

Patterns and predictors of first and subsequent recurrence in women with early breast cancer
por: Geurts, Y. M., et al.
Publicado: (2017)

The use and misuse of risk prediction tools for clinical decision-making
por: van Maaren, Marissa C., et al.
Publicado: (2023)

The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study
por: Gommers, Jessie J. J., et al.
Publicado: (2021)

Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes
por: Choi, Jungyoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tovmasq634dj4ik729haoa13nd